Billiet, Thomas <br/><br/>
A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.  [electronic resource] 

 -  The American journal of gastroenterology  Oct 2016 
 - 1438-1445 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.1038/ajg.2016.306  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--blood<br/>Adult<br/>Anti-Inflammatory Agents--blood<br/>Area Under Curve<br/>Cohort Studies<br/>Female<br/>Gastrointestinal Agents--blood<br/>Histocompatibility Antigens Class I--genetics<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab--blood<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Minisatellite Repeats<br/>Pharmacogenomic Variants--genetics<br/>Receptors, Fc--genetics<br/>Retrospective Studies<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult